37 results
DRS
EX-10.17
VERV
Verve Therapeutics Inc
16 Apr 21
Draft registration statement
12:00am
that vesting occurs, nor does either option grant confer any right to continue vesting or to continued retention as a Service Provider to the Company
S-1
EX-10.16
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
that vesting occurs, nor does either option grant confer any right to continue vesting or to continued retention as a Service Provider to the Company
DRS
EX-10.13
VERV
Verve Therapeutics Inc
16 Apr 21
Draft registration statement
12:00am
.
1.139. “Record Retention Period” has the meaning set forth in Section 5.3.
1.140. “Regulatory Approval” means, with respect to a particular product … [**] after the conclusion of that Calendar Year (the “Record Retention Period”).
5.3.1 Audit of Company and Affiliates. During the Record Retention
S-1
EX-10.12
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
.
1.139. “Record Retention Period” has the meaning set forth in Section 5.3.
1.140. “Regulatory Approval” means, with respect to a particular product … [**] after the conclusion of that Calendar Year (the “Record Retention Period”).
5.3.1 Audit of Company and Affiliates. During the Record Retention
S-1/A
EX-1.1
hed7qece8
14 Jun 21
IPO registration (amended)
6:15am
DEF 14A
fcuaz8
29 Apr 22
Definitive proxy
7:01am
DRS
EX-10.12
gmuo1h9aw5yt93
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.11
wdx o3106d
28 May 21
IPO registration
4:04pm
DRS
EX-10.11
mrv30un x3xulu7vafdv
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.10
dw64tewom07gk8yzht1l
28 May 21
IPO registration
4:04pm
8-K
EX-1.1
2e4zw4v ph
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
EX-1.1
kuxmp1
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
0qu1ki ouyjteb8
1 Jul 22
Shelf registration
4:36pm